Neko Health, the body-scanning startup founded by Daniel Ek, raises another $700 million as it expands its preventive screening service in the United States. The company has developed proprietary body-scanning technology that is paired with bloodwork to evaluate a person’s health. According to reports, the service combines multiple components, including medical imaging, blood tests, proprietary sensors, and clinician review, to generate health assessments.
The new funding round is described as a Series C. It is led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. The company plans to begin its US rollout with a clinic in New York, extending its approach to on-site preventive screening. While the articles emphasize the technology stack and the expansion plan, they do not provide additional details on pricing, patient adoption, regulatory status, or specific clinical outcomes. Overall, the coverage aligns on the scale of the funding ($700 million) and the company’s focus on AI-enabled body scanning combined with bloodwork and clinician oversight for preventive assessment.
